Trump's relationship with cryptocurrency is undergoing a strategic shift. Through his family-backed project, World Free Finance (WLFI), his team is pushing for the regulation of cryptocurrencies and the legalization of stablecoins, highlighting the growing importance of digital assets in high-level strategy. Against this backdrop, the market is shifting towards mature assets with clearly defined use [...]
Wall Street's savviest money managers are shunning high-flying quantum computing pure-play stocks in favor of a cash-rich, industry-leading company that has a laundry list of competitive advantages.
Disagreements within the Fed regarding the pace of easing in 2026 and sharp volatility in the precious metals market in late December amplified the cautious investor sentiment at the start of the new year.
The U.S. health regulatory agency, the FDA, rejected Outlook Therapeutics’ application for approval of its drug Lytenava, which is intended to treat wet AMD.
